Kerry Wentworth is CHIEF REGULATORY OFFICER of Nuvation Bio Inc.. Currently has a direct ownership of 50,000 shares of NUVB, which is worth approximately $104,000. The most recent transaction as insider was on Jun 16, 2025, when has been sold 50,000 shares (Class A Common Stock) at a price of $1.8 per share, resulting in proceeds of $90,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 50K
n/a 3M change
n/a 12M change
Total Value Held $104,000

Kerry Wentworth Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 16 2025
BUY
Open market or private purchase
$90,000 $1.8 p/Share
50,000 Added 50.0%
50,000 Class A Common Stock

Also insider at

FLXN
Flexion Therapeutics Inc
KW

Kerry Wentworth

CHIEF REGULATORY OFFICER
New York, NY

Track Institutional and Insider Activities on NUVB

Follow Nuvation Bio Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NUVB shares.

Notify only if

Insider Trading

Get notified when an Nuvation Bio Inc. insider buys or sells NUVB shares.

Notify only if

News

Receive news related to Nuvation Bio Inc.

Track Activities on NUVB